Delivery Order SPE2DB25D7067-SPE2DB25FSWBZ
- Not listed
- The Defense Logistics Agency awarded a $3,931.56 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-count package), with completion targeted for August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $3,279.40 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 19, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration, with a ceiling value of $14,067.25. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The order is scheduled for ultimate completion by July 29, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,671.43 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 22, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-dose units), with a ceiling value of $3,023.81. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The order is set for ultimate completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,345.60 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count). This contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,837.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Trelegy Ellipta 100-62.5-25 inhalation powder (60-count). This is a non-set-aside competitive award to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $21,853.31 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in 60-dose units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 7, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,154.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,814.31 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The place of performance is located in...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSWBZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,365.23 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This non-competitive, firm fixed-price delivery order was awarded on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used in respiratory disease management, indicating this award supports federal pharmaceutical procurement for military and related healthcare systems. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999 and extends through December 2026. As a prime vendor under this global pharmaceutical support vehicle, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military healthcare programs worldwide. The company's role as a critical federal pharmaceutical distributor enables it to fulfill diverse medical supply requirements across the Defense Health Agency and other government healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/19/25 |